X1000306-1978-79_Part01 — Page 34

Medical and Health Departmental Reports 醫務衛生署年報 All

TABLE 14 (Cont'd.)

Detailed

Age Group

lank

Cause of Death

List No.

vex

8th Revision

All Ages

1..4

5-14

15-44

45-64

65+

Unknown

LI

252

252

1

Certain causes of

760-779

186

166

Perinatal Mortality

UNK

M

Tuberculosis

010-012

013-019

T

A4X

2

440

: : 1

323

F

97

420

Σ

212

9

Nephriti anu Pephrosis

580-584

100

395

207

175

150

10

Congenital Anouuuljes

740-759

130

1

358

306

33

JUN 93'A

2

2

Mjukd

IV IN

26

168

16

29

42

197.

177

41

75

રમ

56

69

131

189

មិនដូ

156,

51

93

96

5

13

1

Suicide and wif infilcted injuries

204

91

76

35

£950-2959

126

56

بازر

36

330

!

147

110

Cirrhosis of Liver

571

223

295

HIH

42

130

50

31

30

44

161

89

CARE RAS

2

Diabetes mellitus

250

All other causes

Residue of

000-1999

ANR

125

1

150

1

203

1

VO QUE

43

57

106

167

Rag

73

94

1,075

25

1,950

34

UNI

&

3,815

60

SLYC

30

22

AN N

261

557

946

152

225

1.473

52

413

782

2,419

21

TABLE 15

LEADING CAULES OF DEATH! 1961, 1968 AND 1978 (RANKING ACCORDING TO 1961)

>

Number of Deaths

Causes of Death

Percentage of Deaths from all Causes

1961

1968

1979

1961

1968

1978-

1961

Rato per 100,000 population

1968

1978

All cause5 2

18,738

19,319

22,843

100.0

100.0 100.0

501.5 508.0 496.9

Themonis, all foras

2,665

1,860

2,067

14.2

9.6

2.1

84.1

48.9

45.3

Malignant neoplasme

2,200

3,582 5,978

12.2

18.5

2€.2

72.0

94.2

129.8

3. Tuberculosis, all forms

1,307

1,483

420

10.2

7.7°

1.€

60.2

39.0

9.1

Heart diseases, including bypertensive diseases

1,866

2,767

3,893

2.9

14.3

17.0

50.9

72.8

34.5

5. Cerebrovascular diseasee

1,401

1,003 3,091

7.5

9.3

13.5

44.2

47.4

66.9

All other causes

2,619 7,324 7,384

46.0

40.6

32.4

272.1 205.7

160.3

ALL PROS

Comments

Approved members can add comments, bookmarks, and private notes.

No comments yet.

Private Research Note

Private notes are available after approval.